ARTICLE
11 September 2024

Another Step Forward For The Patent Eligibility Restoration Act

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
I have been waiting for developments on the Patent Eligibility Restoration Act (PERA) since I testified before the Subcommittee on Intellectual Property of the Senate Judiciary Committee in January 2024, and in the meantime have been encouraging clients in the diagnostics and natural products space not to give up hope.
United States Intellectual Property

I have been waiting for developments on the Patent Eligibility Restoration Act (PERA) since I testified before the Subcommittee on Intellectual Property of the Senate Judiciary Committee in January 2024, and in the meantime have been encouraging clients in the diagnostics and natural products space not to give up hope. PERA finally took another step forward last week, when Representatives Kevin Kiley (R-CA) and Scott Peters (D-CA) introduced a House companion to PERA on September 6, 2024.

As explained in the press release from Rep. Kiley's office, PERA is bipartisan legislation crafted to "restore patent eligibility to inventions across many fields." As Rep. Kiley states:

The U.S. [currently] has one of the most restrictive patent systems in the world due to confusing rulings from the Supreme Court. The Patent Eligibility Restoration Act will allow American inventors to patent a wider variety of inventions that foreign nations, like China, already allow their own innovators to patent.

Legislative interest in PERA stems from "the basic principle that the patent system is central to promoting technology-based innovation," and the intention that restoring eligibility for important technologies "will spark economic growth, create jobs, and provide significant technological advancement for all Americans."

For more information on PERA, this article takes a look at its specific terms and notes that it would essentially turn back the clock to pre-Mayo, pre-Myriad days for life sciences technologies such as diagnostics and "isolated" natural products.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More